Beacon Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	801.16	227.87	306.95	452.19	538.5	337.84
Short-Term Investments	2,338	16.24	15.36	26.33	6.16	5.87
Cash & Short-Term Investments	3,140	244.1	322.32	478.52	544.66	343.71
Cash Growth	-11.86%	-24.27%	-32.64%	-12.14%	58.46%	-43.97%
Accounts Receivable	3,605	2,488	2,758	2,081	1,964	1,933
Other Receivables	-	545.44	224.79	134.55	-	-
Receivables	3,605	5,152	5,610	4,947	2,486	2,337
Inventory	4,119	3,323	2,888	1,992	1,972	1,279
Other Current Assets	4,357	4,149	3,897	1,566	1,301	1,016
Total Current Assets	15,221	12,868	12,717	8,983	6,444	5,216
Property, Plant & Equipment	6,540	6,519	6,187	5,648	4,371	3,319
Long-Term Investments	-	-	-	-	1.03	0.87
Other Intangible Assets	11.05	16.53	27.98	10.79	-	-
Other Long-Term Assets	-	-	-	-	-	0
Total Assets	21,771	19,404	18,932	14,642	10,816	8,536
Accounts Payable	2,588	610.95	905.7	297.45	32.51	113.67
Accrued Expenses	-	317.58	310.19	209.52	448.83	354.26
Short-Term Debt	5,804	5,973	6,699	6,500	3,413	1,884
Current Portion of Long-Term Debt	826.61	911.12	891.43	182.55	216.01	225.9
Current Portion of Leases	29.05	19.42	-	-	-	-
Current Income Taxes Payable	719.05	383.15	246.13	79.54	258.59	-18.65
Other Current Liabilities	51.69	130.94	209.71	220.88	305.13	233.92
Total Current Liabilities	10,019	8,346	9,262	7,490	4,674	2,793
Long-Term Debt	3,013	3,193	2,729	772.48	197.91	387.75
Long-Term Leases	118.58	110.59	-	-	-	-
Pension & Post-Retirement Benefits	1,005	917.28	673.74	323.95	-	-
Long-Term Deferred Tax Liabilities	150.32	169.37	176.57	113.44	-	-
Total Liabilities	14,305	12,737	12,841	8,700	4,872	3,180
Common Stock	2,310	2,310	2,310	2,310	2,310	2,310
Retained Earnings	4,526	3,640	2,892	2,565	2,404	1,639
Comprehensive Income & Other	629.77	716.94	888.6	1,067	1,229	1,406
Shareholders' Equity	7,466	6,667	6,090	5,942	5,944	5,355
Total Liabilities & Equity	21,771	19,404	18,932	14,642	10,816	8,536
Total Debt	9,791	10,207	10,319	7,455	3,827	2,497
Net Cash (Debt)	-6,651	-9,963	-9,997	-6,977	-3,282	-2,153
Net Cash Per Share	-28.79	-43.13	-43.28	-30.20	-14.21	-9.32
Filing Date Shares Outstanding	231	231	231	231	231	231
Total Common Shares Outstanding	231	231	231	231	231	231
Working Capital	5,202	4,522	3,455	1,493	1,770	2,423
Book Value Per Share	32.32	28.86	26.37	25.72	25.73	23.18
Tangible Book Value	7,455	6,651	6,062	5,931	5,944	5,355
Tangible Book Value Per Share	32.27	28.79	26.24	25.68	25.73	23.18
Land	-	663.81	663.81	657.98	624.1	566.06
Buildings	-	2,649	2,208	1,083	978.41	978.41
Machinery	-	5,143	4,745	4,014	3,031	2,465
Construction In Progress	-	1,094	1,130	1,957	1,299	437.22

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.